Corporates: New Requirements For Your Interim Reports

Many companies have issued their 2017 financial reports, disclosing the impacts of IFRS 9 and 15, which became applicable at the start of this year. The next challenge: interim financial reports. The two new standards bring certain changes in this area that corporates shouldn't underestimate.

Accounting standards haven't changed this much in years, if not decades, in terms of financial reporting. IFRS 15 is an obvious one for corporates, but IFRS 9 should be assessed carefully too given that its additional information requirements can vary company by company. And anyway, it is imperative that disclosures are in line with the standard, even if top-line figures are not greatly affected.

Information required in interim financial statements

In accordance with IAS 34, companies must disclose a complete set of financial statements as defined in IAS 1 (the same applies for condensed reports). However, it does permit them to provide less information in interim reports, and to disclose only selected explanatory notes, since these reports will ultimately be read together with the year-end reports. This standard has not been modified by IFRS 9 or 15.

The main requirements of IAS 34 can be found in paragraphs 15 and 16A, in which the following are mentioned as items to disclose:

significant events and transactions (i.e. allowances for financial assets or changes for such allowances, IAS 34.15) any changes in the accounting policies and methods of computation and nature and effect of these changes (IAS 34.16A(a)) changes in estimates relating to figures reported in prior periods (IAS 34.16A) fair value for financial instruments in accordance with IFRS 13.91-93(h), 94-96 and 99, IFRS 7.25,26, and 28-30 (IAS 34.16A(j)) For issuers, this means interim disclosures that will be extensive and time-consuming.

Re: IFRS 15

The new standard asks for extensive disclosures of one of a company's main KPIs: revenue. This didn't use to be the case, but now companies must disclose what's behind the figures as well as "commercial sensitive" information. Many issuers are displeased about the latter requirement. The main challenge could be summed up as walking a line of disclosing enough...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT